Symbols / NTRB Stock $3.76 -3.34% Nutriband Inc.
NTRB (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company has commercial development and clinical supply agreement with Kindeva Drug Delivery. The company was incorporated in 2016 and is headquartered in Orlando, Florida.
Ratings
Current target
$3.76
Low
$15.00
High
$15.00
Mean
$15.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-01-22 | init | Noble Capital Markets | — → Outperform | $13 |
| 2022-07-26 | main | Small Cap Consumer Research | — → Buy | $21 |
- The past five years for Nutriband (NASDAQ:NTRB) investors has not been profitable - Yahoo Finance hu, 29 Jan 2026 08
- Abuse-deterrent fentanyl patch at Nutriband (NASDAQ: NTRB) targets $80M-$200M - Stock Titan ue, 07 Apr 2026 07
- Is Nutriband (NTRB) stock undervalued by investors | Q1 2026: Earnings Beat Estimates - Investment Signal Network - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 08
- NTRB (Nutriband Inc.) Q1 2026 results far outperform loss estimates, post mild revenue gains as shares rise modestly. - Trending Momentum Stocks - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 01
- Nutriband (NASDAQ:NTRB) shareholders are up 27% this past week, but still in the red over the last five years - simplywall.st ue, 30 Dec 2025 08
- NTRB Nutriband Q1 2026 earnings beat estimates by wide margin, shares post modest daily gains. - Outlook Update - UBND thành phố Hải Phòng Wed, 22 Apr 2026 23
- Nutriband stock jumps after FDA meeting for abuse-deterrent fentanyl patch - Investing.com ue, 28 Oct 2025 07
- Nutriband (NASDAQ: NTRB) CEO Highlights AVERSA Technology on Jack Neel Podcast - Barchart.com Fri, 24 Apr 2026 16
- Nutriband Advances Lead Abuse-Deterrent Fentanyl Patch Branding - TipRanks ue, 07 Apr 2026 07
- What’s Driving Nutriband Shares Higher Today? - Stocktwits Mon, 29 Dec 2025 17
- NTRB (Nutriband Inc.) Q1 2026 results far outperform loss estimates, post mild revenue gains as shares rise modestly. - High Volatility - UBND thành phố Hải Phòng hu, 23 Apr 2026 02
- Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval - Yahoo Finance Wed, 02 Jul 2025 07
- Nutriband shareholders approve director slate and increase in preferred stock - Investing.com ue, 03 Feb 2026 08
- NTRB Nutriband posts far better than expected Q1 2026 EPS, yet shares dip slightly on modest year-over-year revenue growth. - Social Momentum Signals - UBND thành phố Hải Phòng Wed, 22 Apr 2026 20
- Is Nutriband (NTRB) Stock Lagging the Market | Price at $3.73, Down 1.36% - Blue Chip Stocks - Xã Vĩnh Công Mon, 06 Apr 2026 07
Insider Transactions
No recent insider transactions.
Financials
Statement View
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
2.14
+2.60%
|
2.09
+0.27%
|
2.08
+46.23%
|
1.42
|
| Operating Revenue |
|
2.14
+2.60%
|
2.09
+0.27%
|
2.08
+46.23%
|
1.42
|
| Cost Of Revenue |
|
1.40
+14.14%
|
1.22
-7.97%
|
1.33
+44.82%
|
0.92
|
| Reconciled Cost Of Revenue |
|
1.40
+14.14%
|
1.22
-7.97%
|
1.33
+44.82%
|
0.92
|
| Gross Profit |
|
0.74
-13.78%
|
0.86
+14.88%
|
0.75
+48.80%
|
0.50
|
| Operating Expense |
|
7.43
+29.63%
|
5.73
+17.06%
|
4.90
+10.47%
|
4.43
|
| Research And Development |
|
3.12
+59.10%
|
1.96
+99.59%
|
0.98
+138.76%
|
0.41
|
| Selling General And Administration |
|
4.31
+14.32%
|
3.77
-3.64%
|
3.92
-2.65%
|
4.02
|
| General And Administrative Expense |
|
—
|
—
|
—
|
4.02
|
| Other Gand A |
|
—
|
—
|
—
|
4.02
|
| Total Expenses |
|
8.83
+26.91%
|
6.96
+11.72%
|
6.23
+16.36%
|
5.35
|
| Operating Income |
|
-6.69
-37.31%
|
-4.87
-17.46%
|
-4.15
-5.55%
|
-3.93
|
| Total Operating Income As Reported |
|
-10.28
-111.10%
|
-4.87
-8.87%
|
-4.48
+26.77%
|
-6.11
|
| EBITDA |
|
-10.18
-98.68%
|
-5.12
-23.56%
|
-4.15
+27.78%
|
-5.74
|
| Normalized EBITDA |
|
-6.21
-36.03%
|
-4.57
-19.64%
|
-3.82
-5.71%
|
-3.61
|
| Reconciled Depreciation |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| EBIT |
|
-10.46
-93.39%
|
-5.41
-20.88%
|
-4.48
+26.12%
|
-6.06
|
| Total Unusual Items |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Total Unusual Items Excluding Goodwill |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Special Income Charges |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Other Special Charges |
|
0.37
-33.62%
|
0.55
|
—
|
-0.05
|
| Impairment Of Capital Assets |
|
3.60
|
0.00
-100.00%
|
0.33
-84.99%
|
2.18
|
| Net Income |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Pretax Income |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Non Operating Interest Income Expense |
|
0.17
+388.75%
|
-0.06
-611.36%
|
-0.01
+93.00%
|
-0.12
|
| Interest Expense Non Operating |
|
0.02
-71.76%
|
0.08
+814.65%
|
0.01
-93.00%
|
0.12
|
| Net Interest Income |
|
0.17
+388.75%
|
-0.06
-611.36%
|
-0.01
+93.00%
|
-0.12
|
| Interest Expense |
|
0.02
-71.76%
|
0.08
+814.65%
|
0.01
-93.00%
|
0.12
|
| Interest Income Non Operating |
|
0.19
+1037.50%
|
0.02
|
0.00
|
—
|
| Interest Income |
|
0.19
+1037.50%
|
0.02
|
0.00
|
—
|
| Other Income Expense |
|
-3.96
-614.84%
|
-0.55
-69.38%
|
-0.33
+84.62%
|
-2.13
|
| Tax Provision |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income From Continuing Operation Net Minority Interest |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income From Continuing And Discontinued Operation |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Net Income Continuous Operations |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Normalized Income |
|
-6.52
-32.21%
|
-4.93
-18.64%
|
-4.16
-2.66%
|
-4.05
|
| Net Income Common Stockholders |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+29.65%
|
-6.37
|
| Otherunder Preferred Stock Dividend |
|
—
|
—
|
0.00
-100.00%
|
0.20
|
| Diluted EPS |
|
-0.99
-43.48%
|
-0.69
-30.19%
|
-0.53
+33.75%
|
-0.80
|
| Basic EPS |
|
-0.99
-43.48%
|
-0.69
-30.19%
|
-0.53
+33.75%
|
-0.80
|
| Basic Average Shares |
|
10.61
+33.36%
|
7.95
-5.97%
|
8.46
+6.64%
|
7.93
|
| Diluted Average Shares |
|
10.61
+33.36%
|
7.95
-5.97%
|
8.46
+6.64%
|
7.93
|
| Diluted NI Availto Com Stockholders |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+29.65%
|
-6.37
|
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Total Assets |
|
7.47
-0.63%
|
7.52
-20.51%
|
9.46
-25.77%
|
12.74
|
| Current Assets |
|
4.79
+369.17%
|
1.02
-62.07%
|
2.69
-50.71%
|
5.47
|
| Cash Cash Equivalents And Short Term Investments |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Cash And Cash Equivalents |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Receivables |
|
0.07
-50.32%
|
0.15
+31.50%
|
0.11
+58.37%
|
0.07
|
| Accounts Receivable |
|
0.07
-50.32%
|
0.15
+31.50%
|
0.11
+58.37%
|
0.07
|
| Inventory |
|
0.21
+25.76%
|
0.17
-26.48%
|
0.23
+74.20%
|
0.13
|
| Raw Materials |
|
0.15
-2.14%
|
0.15
|
—
|
—
|
| Work In Process |
|
0.05
+519.54%
|
0.01
|
—
|
—
|
| Finished Goods |
|
0.02
+90.75%
|
0.01
|
—
|
—
|
| Prepaid Assets |
|
0.20
-7.09%
|
0.21
-42.16%
|
0.37
-1.23%
|
0.37
|
| Total Non Current Assets |
|
2.68
-58.80%
|
6.50
-3.95%
|
6.76
-7.03%
|
7.27
|
| Net PPE |
|
0.70
-13.80%
|
0.81
-16.05%
|
0.96
-3.79%
|
1.00
|
| Gross PPE |
|
1.55
+4.08%
|
1.49
+1.39%
|
1.47
+11.03%
|
1.32
|
| Accumulated Depreciation |
|
-0.85
-25.22%
|
-0.68
-34.42%
|
-0.51
-56.78%
|
-0.32
|
| Machinery Furniture Equipment |
|
1.40
+7.02%
|
1.31
+4.11%
|
1.26
+8.82%
|
1.16
|
| Other Properties |
|
0.14
-17.83%
|
0.18
-15.13%
|
0.21
+26.71%
|
0.16
|
| Goodwill And Other Intangible Assets |
|
1.98
-65.18%
|
5.69
-1.95%
|
5.80
-7.55%
|
6.28
|
| Goodwill |
|
1.72
-65.76%
|
5.02
+0.00%
|
5.02
-6.12%
|
5.35
|
| Other Intangible Assets |
|
0.26
-60.83%
|
0.67
-14.50%
|
0.78
-15.80%
|
0.93
|
| Total Liabilities Net Minority Interest |
|
1.04
-3.51%
|
1.08
+22.13%
|
0.88
+0.34%
|
0.88
|
| Current Liabilities |
|
0.98
-1.63%
|
1.00
+33.46%
|
0.75
-3.93%
|
0.78
|
| Payables And Accrued Expenses |
|
0.70
+2.75%
|
0.68
+27.20%
|
0.53
-16.40%
|
0.64
|
| Current Debt And Capital Lease Obligation |
|
0.13
-20.63%
|
0.16
+216.39%
|
0.05
+52.56%
|
0.03
|
| Current Debt |
|
0.13
+0.76%
|
0.13
+544.29%
|
0.02
+39.81%
|
0.01
|
| Other Current Borrowings |
|
0.13
+0.76%
|
0.13
+544.29%
|
0.02
+39.81%
|
0.01
|
| Current Capital Lease Obligation |
|
0.00
-100.00%
|
0.03
+9.54%
|
0.03
+61.87%
|
0.02
|
| Current Deferred Liabilities |
|
0.16
-1.03%
|
0.16
-3.32%
|
0.16
+53.30%
|
0.11
|
| Current Deferred Revenue |
|
0.16
-1.03%
|
0.16
-3.32%
|
0.16
+53.30%
|
0.11
|
| Total Non Current Liabilities Net Minority Interest |
|
0.06
-27.09%
|
0.08
-40.77%
|
0.13
+33.28%
|
0.10
|
| Long Term Debt And Capital Lease Obligation |
|
0.06
-27.09%
|
0.08
-40.77%
|
0.13
+33.28%
|
0.10
|
| Long Term Debt |
|
0.06
-27.09%
|
0.08
-20.57%
|
0.10
-0.62%
|
0.10
|
| Long Term Capital Lease Obligation |
|
—
|
0.00
-100.00%
|
0.03
|
0.00
|
| Stockholders Equity |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Common Stock Equity |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Capital Stock |
|
0.01
+25.00%
|
0.01
+13.11%
|
0.01
-14.44%
|
0.01
|
| Common Stock |
|
0.01
+25.00%
|
0.01
+13.11%
|
0.01
-14.44%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
11.11
+25.22%
|
8.87
+13.09%
|
7.84
-14.59%
|
9.18
|
| Ordinary Shares Number |
|
11.07
+25.00%
|
8.86
+13.11%
|
7.83
-14.40%
|
9.15
|
| Treasury Shares Number |
|
0.03
+224.00%
|
0.01
+0.00%
|
0.01
-69.52%
|
0.03
|
| Additional Paid In Capital |
|
45.03
+30.74%
|
34.44
+10.77%
|
31.09
+3.76%
|
29.97
|
| Retained Earnings |
|
-38.46
-37.46%
|
-27.98
-24.38%
|
-22.49
-24.89%
|
-18.01
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
|
| Treasury Stock |
|
0.15
+355.09%
|
0.03
+0.00%
|
0.03
-68.75%
|
0.10
|
| Other Equity Adjustments |
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
+0.00%
|
-0.00
|
| Total Equity Gross Minority Interest |
|
6.43
-0.14%
|
6.44
-24.90%
|
8.57
-27.71%
|
11.86
|
| Total Capitalization |
|
6.49
-0.47%
|
6.52
-24.85%
|
8.67
-27.48%
|
11.96
|
| Working Capital |
|
3.81
+16638.78%
|
0.02
-98.83%
|
1.95
-58.49%
|
4.69
|
| Invested Capital |
|
6.62
-0.45%
|
6.65
-23.56%
|
8.69
-27.40%
|
11.97
|
| Total Debt |
|
0.19
-22.77%
|
0.24
+29.86%
|
0.19
+38.07%
|
0.13
|
| Capital Lease Obligations |
|
0.00
-100.00%
|
0.03
-47.72%
|
0.07
+239.19%
|
0.02
|
| Net Tangible Assets |
|
4.45
+493.66%
|
0.75
-72.96%
|
2.77
-50.37%
|
5.58
|
| Tangible Book Value |
|
4.45
+493.66%
|
0.75
-72.96%
|
2.77
-50.37%
|
5.58
|
| Current Notes Payable |
|
—
|
0.00
|
0.00
|
0.00
|
| Line Item | Trend | 2025-01-31 | 2024-01-31 | 2023-01-31 | 2022-01-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-4.63
-31.16%
|
-3.53
-18.09%
|
-2.99
-6.34%
|
-2.81
|
| Cash Flow From Continuing Operating Activities |
|
-4.63
-31.16%
|
-3.53
-18.09%
|
-2.99
-6.34%
|
-2.81
|
| Net Income From Continuing Operations |
|
-10.48
-91.10%
|
-5.49
-22.35%
|
-4.48
+27.41%
|
-6.18
|
| Depreciation Amortization Depletion |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| Depreciation |
|
0.17
-1.53%
|
0.17
-4.95%
|
0.18
-42.29%
|
0.32
|
| Amortization Cash Flow |
|
0.11
+0.00%
|
0.11
-22.76%
|
0.15
|
—
|
| Depreciation And Amortization |
|
0.29
-0.93%
|
0.29
-12.85%
|
0.33
+3.73%
|
0.32
|
| Amortization Of Intangibles |
|
0.11
+0.00%
|
0.11
-22.76%
|
0.15
|
—
|
| Other Non Cash Items |
|
0.03
-0.02%
|
0.03
-79.35%
|
0.15
-73.07%
|
0.56
|
| Stock Based Compensation |
|
1.54
+107.66%
|
0.74
+1.44%
|
0.73
-18.46%
|
0.90
|
| Provisionand Write Offof Assets |
|
0.00
-100.00%
|
0.12
|
0.00
|
—
|
| Asset Impairment Charge |
|
3.60
|
0.00
-100.00%
|
0.33
-84.99%
|
2.18
|
| Operating Gains Losses |
|
0.37
-33.62%
|
0.55
+218.59%
|
0.17
+428.18%
|
-0.05
|
| Gain Loss On Investment Securities |
|
—
|
—
|
0.17
|
—
|
| Change In Working Capital |
|
0.03
-84.73%
|
0.22
+201.78%
|
-0.22
+59.49%
|
-0.54
|
| Change In Receivables |
|
0.07
+148.58%
|
-0.15
-269.54%
|
-0.04
-196.97%
|
0.04
|
| Changes In Account Receivables |
|
0.07
+148.58%
|
-0.15
-269.54%
|
-0.04
-196.97%
|
0.04
|
| Change In Inventory |
|
-0.04
-171.52%
|
0.06
+162.17%
|
-0.10
-23.97%
|
-0.08
|
| Change In Prepaid Assets |
|
0.02
-90.27%
|
0.15
+3292.52%
|
0.00
+101.23%
|
-0.37
|
| Change In Payables And Accrued Expense |
|
0.02
-88.13%
|
0.20
+289.67%
|
-0.10
+27.81%
|
-0.15
|
| Change In Other Working Capital |
|
-0.00
+69.97%
|
-0.01
-109.54%
|
0.06
+191.62%
|
0.02
|
| Change In Other Current Liabilities |
|
-0.03
-9.54%
|
-0.03
+13.77%
|
-0.04
-292.97%
|
-0.01
|
| Investing Cash Flow |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Cash Flow From Continuing Investing Activities |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Net PPE Purchase And Sale |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Purchase Of PPE |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Capital Expenditure |
|
-0.09
-77.82%
|
-0.05
+34.73%
|
-0.08
+2.81%
|
-0.08
|
| Net Business Purchase And Sale |
|
—
|
—
|
—
|
0.00
|
| Financing Cash Flow |
|
8.54
+309.12%
|
2.09
+1203.63%
|
0.16
-97.90%
|
7.63
|
| Cash Flow From Continuing Financing Activities |
|
8.54
+309.12%
|
2.09
+1203.63%
|
0.16
-97.90%
|
7.63
|
| Net Issuance Payments Of Debt |
|
0.28
-86.61%
|
2.09
+11826.73%
|
-0.02
+98.91%
|
-1.63
|
| Issuance Of Debt |
|
0.30
-85.76%
|
2.11
|
0.00
|
0.00
|
| Repayment Of Debt |
|
-0.02
-4.58%
|
-0.02
-11.02%
|
-0.02
+98.91%
|
-1.63
|
| Long Term Debt Issuance |
|
0.30
-85.76%
|
2.11
|
0.00
|
0.00
|
| Long Term Debt Payments |
|
-0.02
-4.58%
|
-0.02
-11.02%
|
-0.02
+98.91%
|
-1.63
|
| Net Long Term Debt Issuance |
|
0.28
-86.61%
|
2.09
+11826.73%
|
-0.02
+98.91%
|
-1.63
|
| Net Common Stock Issuance |
|
8.26
|
0.00
+100.00%
|
-0.12
-101.88%
|
6.31
|
| Common Stock Payments |
|
-0.15
|
0.00
+100.00%
|
-0.12
-13.92%
|
-0.10
|
| Repurchase Of Capital Stock |
|
-0.15
|
0.00
+100.00%
|
-0.12
-13.92%
|
-0.10
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
-100.00%
|
0.30
-89.91%
|
2.94
|
| Changes In Cash |
|
3.82
+355.86%
|
-1.49
+48.65%
|
-2.91
-161.32%
|
4.74
|
| Effect Of Exchange Rate Changes |
|
—
|
—
|
0.00
|
0.00
|
| Beginning Cash Position |
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
+3118.48%
|
0.15
|
| End Cash Position |
|
4.31
+774.69%
|
0.49
-75.17%
|
1.99
-59.41%
|
4.89
|
| Free Cash Flow |
|
-4.72
-31.83%
|
-3.58
-16.72%
|
-3.07
-6.08%
|
-2.89
|
| Interest Paid Supplemental Data |
|
0.01
-23.41%
|
0.01
+72.34%
|
0.00
-77.06%
|
0.02
|
| Income Tax Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
8.41
|
0.00
|
0.00
-100.00%
|
6.42
|
| Issuance Of Capital Stock |
|
8.41
|
0.00
|
0.00
-100.00%
|
6.42
|
| Sale Of Business |
|
—
|
—
|
—
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-07 View
- 8-K2026-02-13 View
- 8-K2026-02-03 View
- 8-K2025-12-30 View
- 10-Q2025-12-11 View
- 8-K2025-10-28 View
- 10-Q2025-09-09 View
- 8-K2025-09-03 View
- 8-K2025-08-07 View
- 8-K2025-07-16 View
- 10-Q2025-05-30 View
- 10-K2025-04-28 View
- 8-K2025-04-09 View
- 8-K2025-02-13 View
- 8-K2025-02-12 View
- 8-K2025-01-29 View
- 8-K2024-12-30 View
- 10-Q2024-12-04 View
- 42024-12-02 View
- 42024-11-29 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|